Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories. Although there were many pieces and contributors to the final product, it was first conceived of and created by Gregory Pincus and Margaret Sanger through the Worcester Foundation in Worcester, Massachusetts, and was distributed by Searle, located in Chicago. This technology is important to the history of embryology because it changed the way people viewed birth control and revolutionized women's birth control methods. There is an extensive literature on the cultural and societal effects of the pill; for example, the effect it had on women's health care and how it changed perceptions of female sexuality.

Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955. These two types of synthetic progesterone are important to the history of embryology because they facilitated the development and creation of the birth control pill, which changed the way people viewed birth control and revolutionized women's birth control methods.

Katharine Dexter McCormick, who contributed the majority of funding for the development of the oral contraceptive pill, was born to Josephine and Wirt Dexter on 27 August 1875 in Dexter, Michigan. After growing up in Chicago, Illinois, she attended the Massachusetts Institute of Technology (MIT), where she graduated in 1904 with a BS in biology. That same year, she married Stanley McCormick, the son of Cyrus McCormick, inventor and manufacturer of the mechanized reaper. Katharine's father was a prominent Chicago lawyer, so this marriage created the accumulation of great wealth and power. Her primary contribution to society was her commitment to reproductive reform.

Gregory Goodwin Pincus, one of the original researchers responsible for the development of the first oral contraceptive pill, was born in Woodbine, New Jersey, on 19 April 1903 to Russian Jewish parents. In 1924 Pincus received his BS degree from Cornell University, and in 1927 he received his MS and PhD from Harvard University, having studied under William Ernest Castle and William John Crozier. After this, Pincus studied at Cambridge University with Francis Hugh Adam Marshall and John Hammond, both reproductive biologists, and at the Kaiser Wilhelm Institute with Richard Goldschmidt, a geneticist.

Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B. This technology is important in part because it expands women's reproductive rights by giving them greater control over their fertility. The mechanism of action of Plan B also raises questions about the moral status of the zygote.